Return to our Home Page
Novagen Home Page

Tech Resources
TB342 KOD XL DNA Polymerase
MSDS - English
Other Languages
Selected Citations
Store
-20°C-20°C
Ship
Shipped with Blue Ice or with Dry IceBlue or dry ice
Note: Store and Ship conditions may differ.
See Key





  KOD XL DNA Polymerase
Cat. No. 71087  
All Categories » Novagen » PCR and Cloning » Thermostable DNA Polymerases » KOD DNA Polymerase and PCR Kits
Product Description

KOD XL DNA Polymerase* is an optimized blend of KOD DNA Polymerase and a mutant form of KOD that is deficient in 3′→5′ exonuclease activity (Nishioka 2002). This enzyme mixture is designed for reliable amplification of long, complex targets with robust yield and high accuracy. It can also be used for incorporation of derivatized dNTPs in PCR amplicons (Sawai 2002, Sawai 2001). KOD XL DNA Polymerase generates a mixture of PCR products with blunt and 3′-dA overhangs, suitable for cloning with Novagen Perfectly Blunt®, AccepTor™, and LIC Vector Kits.

Features and Benefits:

  • Ideal for amplification of large DNA fragments from purified DNA or crude samples
  • Amplifies DNA templates up to 30 kbp
  • Successfully amplifies GC-rich sequences
  • Efficiently incorporates derivatized dNTPs

References:
Nishioka, M., et al. 2002. J. Biotechnol. 88, 141. Sawai, H., et al. 2002. Bioconjugate Chem. 13, 309. Sawai, H., et al. 2001. Chem. Commun. 24, 2604.

SourceRecombinant Thermococcus kodakaraensis KOD1 DNA polymerase expressed in E. coli (wild type and exonuclease-deficient forms)
Concentration2.5 U/µl
EndonucleaseNone detected
Nicking activityNone detected
Amplification effiencyFunctional PCR
Storage–20°C

*Manufactured by Toyobo and distributed by Novagen. Not available from Novagen in Japan. Licensed under US Patent Number 5,436,149 owned by Takara Shuzo Co., Ltd.

Note: Purchase of this product includes an immunity from suit under patents specified in the product insert to use only the amount purchased for the purchaser's own internal research. No other patents rights (such as 5' Nuclease Process patent rights) are conveyed expressly, by implication, or by estoppel. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California, 94404, USA.

Unit Activity: One unit is defined as the amount of enzyme that will catalyze the incorporation of 10 nmol of dNTP into acid-insoluble form in 30 min at 75°C, in a reaction containing 20 mM Tris-HCl (pH 7.5 at 25°C), 8 mM MgCl2, 7.5 mM DTT, 50 µg/ml BSA, 150 µM each of dATP, dCTP, dGTP, dTTP (a mix of unlabeled and [3H]dTTP), and 150 µg/ml activated calf thymus DNA.

Components:
250 U or 5 × 250 UKOD XL DNA Polymerase (2.5 U/µl)
1.2 ml or 5 × 1.2 ml10X PCR Buffer for KOD XL DNA Polymerase
1 ml or 5 × 1 mldNTP Mix (2 mM each)
 

Need additional information about this product? Email our Technical Service department at: novatech@novagen.com

 Related information for this product is available:

EMD Chemicals Inc. USD list price is displayed (pricing with local distributors may vary). NOTE: In Stock status is based on item availability worldwide.

Cat. No.
Size
In Stock
Select Country Above
For Pricing Information
71087-3250 UY$256.00
71087-41250 UY$993.00

Related Products:
71085: KOD DNA Polymerase
71086: KOD Hot Start DNA Polymerase
71087: KOD XL DNA Polymerase

Related Literature:

Novagen inNovations Newsletter 28

PCR Tools Brochure

Material Safety Data Sheets:
71087: KOD XL DNA Polymerase - English
Bulgarian
Danish
Dutch
Finnish
French
German
Greek
Hungarian
Italian
Korean
Norwegian
Polish
Portuguese
Spanish
Swedish

Related Categories:
All Categories » Novagen » PCR and Cloning » Thermostable DNA Polymerases » KOD DNA Polymerase and PCR Kits

Selected Citations:
  1. Gang Wu, et al. (2006) Simplified gene synthesis: A one-step approach to PCR-based gene construction. Journal of Biotechnology 124, 496–503.
  2. Tom S. Kim, et al. (2005) Delayed dark adaptation in 11-cis-retinol dehydrogenase deficient mice: a role of RDH11 in visual processes in vivo. Journal of Biological Chemistry 280, 8694-8704.
  3. Yukio Kuwada, et al. (2003) Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. International Journal of Oncology 22, 765-771.
  4. Yoko Ogawara, et al. (2002) Akt enhances Mdm2-mediated ubiquitination and degradation of p53. Journal of Biological Chemistry 277, 21843-21850.
  5. Hiroshi Oyama, et al. (2002) A CLN2-related and thermostable serine-carboxyl proteinase, kumamolysin: cloning, expression, and identification of catalytic serine residue. 131, [757-765.
  6. Ichiro Tabuchi, et al. (2002) An efficient ligation method in the making of an in vitro virus for in vitro protein evolution. Biological Procedures Online 4, 49-54.
  7. Toshiyuki Sasagawa, et al. (2001) High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiology Biomarkers and Prevention 10, 45-52.
  8. Toru Tsuji, Michiko Onimaru and Hiroshi Yanagawa. (2001) Random multi-recombinant PCR for the construction of combinatorial protein libraries. Nucleic Acids Research 29, e97.
  9. Kunitoshi Mitsumori, et al. (2000) Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea. Carcinogenesis 21, 1039-1042.
  10. Akihiro Saito, et al. (2000) Transcriptional co-regulation of five chitinase genes scattered on the Streptomyces coelicolor A3(2) chromosome. Microbiology 146, 2937-2946.

...see all selected citations...